Literature DB >> 3710614

Occurrence of a fetal fibroblast phenotype in familial breast cancer.

S L Schor, J A Haggie, P Durning, A Howell, L Smith, R A Sellwood, D Crowther.   

Abstract

We have previously shown that fetal and adult human skin fibroblasts display distinctive migratory phenotypes when cultured on 3-dimensional collagen gels in vitro. In the present study, we have used this information to assess the migratory behavior of fibroblasts obtained from patients with either benign or malignant breast disease, and correlated this with the presence of a family history of breast cancer. We have observed that fibroblasts from 17/34 patients with no previous family history of breast cancer displayed fetal-type behavior in our assay system; in contrast, fibroblasts from 15/16 patients with a positive family history of breast cancer behaved abnormally. This apparently increased probability of expressing a fetal-type migratory phenotype in the patients with a family history is statistically significant (p less than 0.008). Skin fibroblasts obtained from 2 healthy and unaffected first-degree relatives (one male and one female) of patients with a family history of breast cancer also exhibited a fetal-type migratory phenotype.

Entities:  

Mesh:

Year:  1986        PMID: 3710614     DOI: 10.1002/ijc.2910370606

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

Review 1.  Mammary stroma in development and carcinogenesis.

Authors:  Teruyo Sakakura; Yuka Suzuki; Robert Shiurba
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-04-21       Impact factor: 2.673

Review 2.  Role of TGF beta in the anti-estrogen response/resistance of human breast cancer.

Authors:  J R Benson; M Baum; A A Colletta
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-10       Impact factor: 2.673

Review 3.  Cancer-associated fibroblasts in digestive tumors.

Authors:  Lei Huang; A-Man Xu; Sha Liu; Wei Liu; Tuan-Jie Li
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

4.  Epigenetic reversion of breast carcinoma phenotype is accompanied by changes in DNA sequestration as measured by AluI restriction enzyme.

Authors:  Tone Sandal; Klara Valyi-Nagy; Virginia A Spencer; Robert Folberg; Mina J Bissell; Andrew J Maniotis
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

5.  Mechanism of action of the migration stimulating factor produced by fetal and cancer patient fibroblasts: effect on hyaluronic and synthesis.

Authors:  S L Schor; A M Schor; A M Grey; J Chen; G Rushton; M E Grant; I Ellis
Journal:  In Vitro Cell Dev Biol       Date:  1989-08

Review 6.  Tumour-stroma interactions in carcinogenesis: basic aspects and perspectives.

Authors:  H Kiaris; I Chatzistamou; Ch Kalofoutis; H Koutselini; Ch Piperi; A Kalofoutis
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

Review 7.  Alternative mechanisms of action of anti-oestrogens.

Authors:  A A Colletta; J R Benson; M Baum
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts.

Authors:  A M Grey; A M Schor; G Rushton; I Ellis; S L Schor
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 9.  Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment.

Authors:  Luke Bu; Hideo Baba; Naoya Yoshida; Keisuke Miyake; Tadahito Yasuda; Tomoyuki Uchihara; Patrick Tan; Takatsugu Ishimoto
Journal:  Oncogene       Date:  2019-02-28       Impact factor: 9.867

10.  The tumor microenvironment: the making of a paradigm.

Authors:  Isaac P Witz
Journal:  Cancer Microenviron       Date:  2009-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.